Accepted at 2:22 p.m. Sep, 02, 2024 by Ahmed7
Author: rpmoore
Related Note: 1488855002412
Rationale for change

AMBOSS https://next.amboss.com/us/article/BN0zWg?q=nsaids#0kcemc0

FA 2024 pg. 495

AMBOSS actually only lists protective prostaglandins, but FA2024 lists both (and Sketchty and other sources reference both) however I think it's confusing as NSAIDs MOA -> GI bleeding involves decreased synthesis of TXA2 and prostaglandins.

alternatively, we could make prostaglandins a cloze 2 but i couldn't find any sources that emphasized TXA2 as being more important in NSAID-related GI bleeding
Source: AMBOSS - https://next.amboss.com/us/article/BN0zWg?q=nsaids#0kcemc0

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::06_Platelets::05_Antiplatelet_Medications #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::04_Antiplatelet_Drugs::Extra #AK_Step1_v12::#Physeo::09_Pharm::09_Musculoskeletal::04_NSAIDs #AK_Step1_v12::#B&B::13_Immunology::03_Pharm::01_Glucocorticoids_and_NSAIDs #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::^Other::^EXPN #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::03_NSAIDs #AK_Step1_v12::#UWorld::Step::713 #AK_Other::!AK_UpdateTags::AnKing_Image::Aiman::Arachidonic_Acid_Pathway #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-inflammatory::01_NSAIDs #AK_Step1_v12::#UWorld::COMLEX::23825 #AK_Step1_v12::^Systems::Musculoskeletal::Pharmacology #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Biochemistry::Arachidonic_Acid_Pathway #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::06_Antiplatelet_Drugs::Extra #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::05_Nonsteroidal_anti-inflammatory_drugs #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::05_NSAIDs #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step1_v12::#Bootcamp::Pharmacology::04_Side_Effects_and_Toxins::01_Age_Considerations_for_Pharmacokinetics